A Study to Evaluate the Efficacy and Safety of SHR-1703 in Subjects With Eosinophilic Granulomatosis With Polyangiitis （EGPA）

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(2 sites)

China

Beijing Hospital, Beijing, Beijing Municipality

The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, Zhejiang